Telomir Pharmaceuticals Inc. (TELO)
TELO trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.09
-0.91% on the day
Market cap
$80.2M
Micro cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TELO on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001971532 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | FL |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2025-02-14 |
| Latest annual report | 10-K | 2026-03-17 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-06 |
| Latest proxy | DEFA14A | 2026-08-19 |
Source: SEC EDGAR submissions feed, 146 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PMN | ProMIS Neurosciences Inc. Common Shares (ON) | $8.66 | -8.36% | $77.7M |
| RFL | Rafael Holdings Inc. | $1.49 | -1.97% | $77.5M |
| NTHI | NeOnc Technologies Holdings Inc. | $2.60 | -4.95% | $77.2M |
| EQ | Equillium Inc. | $1.32 | -12.00% | $83.7M |
| INCR | Intercure Ltd. | $5.03 | +1.62% | $75.5M |
| ACRV | Acrivon Therapeutics Inc. | $1.75 | -7.89% | $75.0M |
| LFVN | Lifevantage Corporation Common Stock (Delaware) | $5.95 | -0.50% | $74.9M |
| HRTX | Heron Therapeutics Inc. | $0.3906 | -6.01% | $74.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier